A Study of Dabrafenib Plus Cetuximab/Panitumumab With FOLFOX in the First Line of Therapy in People With Metastatic Colorectal Cancer
Clinical trial NCT06978400 · RECRUITING
Trial details
- NCT number
- NCT06978400
- Sponsor
- Blokhin's Russian Cancer Research Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-01
- Primary completion
- 2027-11-10
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.